Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System

INTRODUCTION: This study was conducted using an integrated retrospective database to evaluate the effectiveness of Omnitrope(®) (Sandoz) on children with growth hormone deficiency (GHD), idiopathic short stature (ISS), and Turner Syndrome (TS) who switched from a non-Omnitrope recombinant human grow...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Ther
Main Authors: Rashid, Nazia, Saenger, Paul, Wu, Yi-Lin, Woehling, Heike, Frankel, Matthew, Lifshitz, Fima, Muenzberg, Michael, Rapaport, Robert
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2014
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254867/
https://ncbi.nlm.nih.gov/pubmed/25096555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-014-0017-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki